“…As a result of this work, several pharmacological agents are now known to induce a protective phenotype similar to that seen with IPC, such as PC with ethanol, adenosine receptor agonists, bradykinin, nitric oxide (NO) donors, and exogenous calcitonin gene-related peptide (4,9,26,41,43). Indeed, our own work (13,14,23,24,36,37,47) has established that these agents induced the development of a protective anti-inflammatory phenotype in postcapillary venules, such that these vessels fail to support adhesion molecule expression, leukocyte rolling and adhesion, and increased vascular permeability when the small bowel is subsequently exposed to prolonged ischemia-reperfusion (I/R).…”